L-arginine supplementation prolongs duration of exercise in congestive heart failure;L-arginina poprawia tolerancjȩ wysiłku w niewydolnoś ci serca

Kardiologia Polska

Volumn 60, Issue 4, 2004, Pages 348-353

  Bednarz, Bronisław ^a   Jaxa Chamiec, Tomasz ^a   Gȩbalska, Jadwiga ^a   Herbaczyńska Cedro, Krystyna ^b,c   Ceremuzyński, Leszek ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Antioxidants; Congestive heart failure; Exercise; L arginine; Nitric oxide

Indexed keywords

ANTICOAGULANT AGENT; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOCYTE ANTIGEN; LIPID PEROXIDE; NITRATE; NITRIC OXIDE; OXYGEN RADICAL; PLACEBO; THIOL DERIVATIVE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; HUMAN; LEUKOCYTE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

EID: 2342559944     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hirooka Y., Imaizumi T., Tagawa T. et al.: Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994, 90, 658-68.
2. Katz S.D., Krum H., Khan T., Knecht M.: Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J. Am. Coll. Cardiol. 1996, 28, 585-90.
3. Kubota T., Imaizumi T., Oyama J. et al.: L-arginine increases exercise-induced vasodilation of the forearm in patients with heart failure. Jap. Circ. J. 1997, 61, 471-480.
4. Koifman B., Wollman Y., Bogomolny N. et al.: Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J. Am. Coll. Cardiol. 1995, 26, 1251-1256.
5. Hambrecht R., Hilbrich L., Erbs S. et al.: Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J. Am. Coll. Cardiol. 2000, 35, 706-713.
6. Rector T.S., Bank A.J., Mullen K.A. et al.: Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996, 93, 2135-2141.
7. Chin-Dusting J.P.F., Kaye D.M., Lefkovits J. et al.: Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J. Am. Coll. Cardiol. 1996, 27, 1207-1213.
8. Singal P.K., Khaper N., Palace V., Kumar D.: The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res. 1998, 40, 426-432.
9. Wascher T.C., Posch K., Wallner S., Hermetter A.: Vascular effects of L-arginine; anything beyond a substrate for the NO-synthase? Biochem. Biophys. Res. Commun. 1997, 234, 35-38.
10. Buege J., Aust S.: Microsomal lipid peroxidation. In: Fleisher S, Packer L, eds. Methods in Enzymology. New York: Academic Press, 1978, 52, 302-310.
11. Ellman GI.: Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.
12. Herbaczynńska-Cedro K., Kłosiewicz-Wa̧sek B., Cedro K. et al.: Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur. Heart J. 1995, 16, 1044-1049.
13. Ceremużyński L., Chamiec T., Herbaczyńska-Cedro K.: Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am. J. Cardiol. 1997, 80, 331-333.
14. Bednarz B., Wolk R., Chamiec T. et al.: Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. Int. J. Cardiol. 2000, 75, 205-210.
15. Zanzinger J., Czachurski J., Seller H.: Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ. Res. 1994, 75, 1073-1077.
16. Boger R.H., Bode-Boger S.M., Szuba A. et al.: Asymetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 1998, 98, 1842-1847.
17. Nagase S., Takemura K., Ueda A. et al.: A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem. Biophys. Res. Commun. 1997, 233, 150-153.
18. Kaye D.M., Ahlers B.A., Autelitano D.J., Chin-Dusting J.P.F.: In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation 2000, 102, 2707-2712.
19. Adams M.R., Phu C.V., Stocker R., Celermajer D.S.: Lack of antioxidant activity of the antiatherogenic compound L-arginine. Atherosclerosis 1999, 146, 329-335.